Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

Gland Pharma Ltd

GLAND.NS ✓ COMPLIANTFree checks used up today ☆ Track — members
NSE · Healthcare · Pharmaceuticals ·
India Mid Cap Analyst: BUY
Last Close
$32.52
▲ +0.70%
Market Cap $5.37B · Vol 300.30K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
45.27
FWD: 34.42
Market Cap
$5.37B
Mid Cap
Div Yield
0.65%
Annual dividend
EPS Growth
+27.31%
YoY
RSI (14)
52.89
Momentum
Beta
0.23
vs Market
52W High
$33.31
0.76% below
52W Low
$16.53
91.88% above
Volume
300.30K
Avg 389.41K
P/B
2.70
Price-to-book
ROE
10.78%
Return on equity
Free Float
54.25%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, Gland Pharma Ltd (GLAND.NS) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GLAND.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
+9.52%
1M
+6.78%
3M
+23.00%
6M
+76.83%
YTD
+79.79%
1Y
+62.45%
3Y
+75.15%
5Y
-16.33%
Financials & Valuation
TTM · Annual
Total Revenue$688.09M
Net Income$109.92M
Revenue Growth (YoY)+19.57%
Gross Margin54.51%
Operating Margin18.76%
Net Profit Margin15.98%
ROE10.78%
ROA · ROIC12.34% · 10.30%
P/E Ratio45.27
Forward P/E (FY1)34.42
PEG Ratio0.58
P/S4.35
P/B2.70
P/FCF37.97
EPS Growth+27.31%
Outstanding Shares165.01M
Technical Indicators
50-Day SMA$30.91
200-Day SMA$23.89
RSI (14)52.89
Beta0.23
52-Week High$33.31
52-Week Low$16.53
Volume Today300.30K
Avg Daily Volume (30D)389.41K
Relative Volume0.77x
Volatility (10D)33.46
Volatility (30D)31.36
Free Float54.25%
AAOIFI Certified Shariah Advisor and Auditor certificate